Cargando…

Monoamine oxidase A and organic cation transporter 3 coordinate intracellular β(1)AR signaling to calibrate cardiac contractile function

We have recently identified a pool of intracellular β(1) adrenergic receptors (β(1)ARs) at the sarcoplasmic reticulum (SR) crucial for cardiac function. Here, we aim to characterize the integrative control of intracellular catecholamine for subcellular β(1)AR signaling and cardiac function. Using an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Zhao, Meimi, Xu, Bing, Bahriz, Sherif M. F., Zhu, Chaoqun, Jovanovic, Aleksandra, Ni, Haibo, Jacobi, Ariel, Kaludercic, Nina, Di Lisa, Fabio, Hell, Johannes W., Shih, Jean C., Paolocci, Nazareno, Xiang, Yang K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288959/
https://www.ncbi.nlm.nih.gov/pubmed/35842861
http://dx.doi.org/10.1007/s00395-022-00944-5
Descripción
Sumario:We have recently identified a pool of intracellular β(1) adrenergic receptors (β(1)ARs) at the sarcoplasmic reticulum (SR) crucial for cardiac function. Here, we aim to characterize the integrative control of intracellular catecholamine for subcellular β(1)AR signaling and cardiac function. Using anchored Förster resonance energy transfer (FRET) biosensors and transgenic mice, we determined the regulation of compartmentalized β(1)AR-PKA signaling at the SR and plasma membrane (PM) microdomains by organic cation transporter 3 (OCT3) and monoamine oxidase A (MAO-A), two critical modulators of catecholamine uptake and homeostasis. Additionally, we examined local PKA substrate phosphorylation and excitation–contraction coupling in cardiomyocyte. Cardiac-specific deletion of MAO-A (MAO-A-CKO) elevates catecholamines and cAMP levels in the myocardium, baseline cardiac function, and adrenergic responses. Both MAO-A deletion and inhibitor (MAOi) selectively enhance the local β(1)AR-PKA activity at the SR but not PM, and augment phosphorylation of phospholamban, Ca(2+) cycling, and myocyte contractile response. Overexpression of MAO-A suppresses the SR-β(1)AR-PKA activity and PKA phosphorylation. However, deletion or inhibition of OCT3 by corticosterone prevents the effects induced by MAOi and MAO-A deletion in cardiomyocytes. Deletion or inhibition of OCT3 also negates the effects of MAOi and MAO-A deficiency in cardiac function and adrenergic responses in vivo. Our data show that MAO-A and OCT3 act in concert to fine-tune the intracellular SR-β(1)AR-PKA signaling and cardiac fight-or-flight response. We reveal a drug contraindication between anti-inflammatory corticosterone and anti-depressant MAOi in modulating adrenergic regulation in the heart, providing novel perspectives of these drugs with cardiac implications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00395-022-00944-5.